Fatigue News and Research

RSS

Novartis receives priority review status from FDA for heart failure medicine LCZ696

Novartis announced today that the US Food and Drug Administration has granted priority review for LCZ696, an investigational medicine for the treatment of heart failure with reduced ejection fraction (HFrEF). The designation is intended to accelerate the review of therapies that offer a significant improvement in the safety or effectiveness of the treatment, prevention or diagnosis of a serious condition.

16 Feb 2015

$Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC$

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Eisai Inc. announced today that the U.S. Food and Drug Administration approved the company's receptor tyrosine kinase inhibitor LENVIMA (lenvatinib) for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC).

13 Feb 2015

Camp Twinkletoes improves lives of children suffering from juvenile arthritis

Throughout NSW, there are more than 6,000 children suffering from the extreme pain and fatigue of juvenile arthritis. Usually thought of as an ‘older persons’ disease, arthritis in children is a very real condition, and in extreme cases can even result in death.

13 Feb 2015

Lenvatinib trial offers hope for thyroid cancer patients

A new targeted therapy called lenvatinib has been shown to improve progression-free survival among patients with advanced thyroid cancer that is not responsive to iodine-131.

13 Feb 2015

Doctor's Best adds three new sports nutrition powders to its science-based supplement portfolio

Doctor's Best has introduced three new sports nutrition powders – Creatine, Branched Chain Amino Acids (BCAA) and L-Arginine - into its science-based supplement portfolio.

13 Feb 2015

$Lenvatinib therapy improves survival in patients with advanced radioiodine-refractory thyroid cancer$

Lenvatinib therapy improves survival in patients with advanced radioiodine-refractory thyroid cancer

In a pivotal Phase III study led by researchers at The University of Texas MD Anderson Cancer Center, the oral anti-angiogenic therapy lenvatinib has shown dramatic improvement in progression-free survival in patients with advanced radioiodine-refractory thyroid cancer.

12 Feb 2015

New online tool helps facilitate discussion between health professionals and patients presenting with fatigue

In Australia, people often seek medical advice because of fatigue. However it is often not associated with underlying disease, particularly in young to middle aged adults, and may remain unexplained.

11 Feb 2015

IOM committee identifies five main symptoms to diagnose ME/CFS

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome -- commonly referred to as ME/CFS -- is a legitimate, serious, and complex systemic disease that frequently and dramatically limits the activities of affected individuals, says a new report from the Institute of Medicine.

11 Feb 2015

Study shows low-dose oral iron supplementation after blood donation reduces hemoglobin recovery time

Among blood donors with normal hemoglobin levels, low-dose oral iron supplementation, compared with no supplementation, reduced the time to recovery of the postdonation decrease in hemoglobin concentration in donors with low or higher levels of a marker of overall iron storage (ferritin), according to a study in the February 10 issue of JAMA.

11 Feb 2015

New IOM report presents diagnostic criteria for chronic fatigue syndrome

A new report from the Institute of Medicine presents new diagnostic criteria for chronic fatigue syndrome and examines whether a new name for the condition is warranted.

11 Feb 2015

GI Society releases video to spread awareness about hepatitis C

As many as 350,000 Canadians could be suffering with hepatitis C, many of whom are unaware that they are infected, thus continuing to spread the virus. Although there is a vaccine to prevent the spread of the hepatitis A and hepatitis B viruses, there is no vaccine for hepatitis C. The good news is that with new treatments, hepatitis C is now a curable disease.

10 Feb 2015

Three groups of researchers receive BRAIN Initiative funding to improve artificial limb technology

Three groups of researchers who have received support from the National Institutes of Health will obtain funding from the President's BRAIN Initiative to improve artificial limb technology. The new awards will be funded and administered by the Defense Advanced Research Projects Agency and will build on the fundamental discoveries that were made possible by NIH support.

10 Feb 2015

Physical, psychosocial factors can significantly increase risk of low back pain

New research reveals the physical and psychosocial factors that significantly increase the risk of low back pain onset. In fact results published in Arthritis Care & Research, a journal of the American College of Rheumatology, show that being engaged in manual tasks involving awkward positions will increase the risk of low back pain by eight times. Those who are distracted during activities or fatigued also significantly increase their risk of acute low back pain.

9 Feb 2015

February is American Heart Month

February is American Heart Month, the perfect time to be reminded to take care of your heart. "Heart disease is the leading cause of death for both men and women," says Gerald Sotsky, M.D., Chair of Cardiac Services, Valley Medical Group.

9 Feb 2015

Chinese researchers achieve major breakthrough in nano-carrier drugs for pancreatic cancer

At the "Symposium on the Application of Genetic Testing in Individualized Diagnosis and Treatment of Tumor" recently held in Tianjin, the research team led by Professor Hao Jihui of the Pancreas Oncology Department of Tianjin Medical University Cancer Hospital announced that they had achieved a major breakthrough in the field of nano-carrier drugs for pancreatic cancer.

6 Feb 2015

Study: Lyme disease costs the U.S. health care system up to $1.3 billion a year

Lyme disease, transmitted by a bite from a tick infected by the Borrelia burgdorferi bacteria, had long been considered easy to treat, usually requiring a single doctor's visit and a few weeks of antibiotics for most people.

6 Feb 2015

Women’s risk factors for heart disease

Heart disease is often thought of as a health problem for men, but more and more women die of heart disease each year than men, and from any other disease including breast cancer.

4 Feb 2015

News study finds association between chronic fatigue syndrome and early menopause

A newfound link between chronic fatigue syndrome (CFS) and early menopause was reported online today in Menopause, the journal of The North American Menopause Society.

4 Feb 2015

Amgen's biosimilar Phase 3 rheumatoid arthritis study meets primary and secondary endpoints

Amgen today announced a Phase 3 study evaluating the efficacy and safety of biosimilar candidate ABP 501 compared with Humira® (adalimumab) in patients with moderate-to-severe rheumatoid arthritis met its primary and key secondary endpoints.

4 Feb 2015

Jersey Shore University Medical Center offers robotic-assisted laparoscopic sleeve gastrectomy

For many people, losing weight is a personal and ongoing battle. At the Center for Weight-Loss Surgery at Jersey Shore University Medical Center, new options are available for those making the life changing decision to lose weight, including minimally invasive techniques such as robotic-assisted laparoscopic sleeve gastrectomy.

31 Jan 2015

Fatigue News and Research

Novartis receives priority review status from FDA for heart failure medicine LCZ696

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Camp Twinkletoes improves lives of children suffering from juvenile arthritis

Lenvatinib trial offers hope for thyroid cancer patients

Doctor's Best adds three new sports nutrition powders to its science-based supplement portfolio

Lenvatinib therapy improves survival in patients with advanced radioiodine-refractory thyroid cancer

New online tool helps facilitate discussion between health professionals and patients presenting with fatigue

IOM committee identifies five main symptoms to diagnose ME/CFS

Study shows low-dose oral iron supplementation after blood donation reduces hemoglobin recovery time

New IOM report presents diagnostic criteria for chronic fatigue syndrome

GI Society releases video to spread awareness about hepatitis C

Three groups of researchers receive BRAIN Initiative funding to improve artificial limb technology

Physical, psychosocial factors can significantly increase risk of low back pain

February is American Heart Month

Chinese researchers achieve major breakthrough in nano-carrier drugs for pancreatic cancer

Study: Lyme disease costs the U.S. health care system up to $1.3 billion a year

Women’s risk factors for heart disease

News study finds association between chronic fatigue syndrome and early menopause

Amgen's biosimilar Phase 3 rheumatoid arthritis study meets primary and secondary endpoints

Jersey Shore University Medical Center offers robotic-assisted laparoscopic sleeve gastrectomy

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News